QAM Hub QAM Hub
Home / Blog / Test Management Tool Evaluation Checklist: What to Check Before You Sign

Test Management Tool Evaluation Checklist: What to Check Before You Sign

By Mike Krasnovskyi · Published
Checklist panel beside a data crate moving between two test management platforms, with attachment icons falling out in transit

Most test management tool evaluations fail on three things, and none of them is the feature list: whether the tool binds your test data to your Jira estate, whether you can get your data back out with attachments intact, and which capabilities sit behind the tier above the one you are about to buy. Feature comparison tables are easy to build and almost never decide the outcome, because by month three every serious contender covers cases, runs, milestones and coverage. What decides the outcome is the cost of the parts you cannot see from a demo. This checklist is ordered by what breaks first in a real rollout, not alphabetically and not by how impressive a criterion looks in a scoring matrix.

If you have twenty minutes rather than a week, do three things. Ask each vendor where the data physically lives and what happens to it if you cancel. Import a hundred of your real test cases into the trial, export them again, and diff the result. Read the vendor's own feature-tier page, not the pricing page, and mark which of the things you just promised your team are one tier up.

The first question is whether your test data lives inside Jira

This single decision removes half the market before you evaluate anything else, and it is the one teams answer last. Jira-native tools store tests as Jira issues. Xray and Zephyr work this way, and licensing and hosting follow the Jira instance along with the data. Xray Cloud documents its available regions as the United States, Europe (Frankfurt), Germany (Frankfurt) and Australia (Sydney), and requires Xray Standard and Xray Enterprise to be deployed in the same location for Enterprise customers. SmartBear's Zephyr documentation lists US (Oregon) and EU (Dublin) as the residency options, states that data residency is available only for new Jira instances, and excludes BDD test executions and data processed by its no-code automation feature from the residency guarantee. Read that as a planning constraint rather than a defect: your test management region, and to a large degree your seat count, is decided by an estate you may not control.

The upside is real. Tests appear in the same board, the same JQL, the same permission scheme, and nobody has to reconcile two user lists. For a team whose entire delivery process already runs through Jira and whose testers are Jira users anyway, that integration is worth more than any independent tool's feature advantage.

The cost is also real and it shows up later. Test case volume grows faster than issue volume, and a suite of 20,000 cases living as issues affects the performance and the administration of an instance that other teams depend on. Reporting is constrained by what a Jira-based report can express. And when the company migrates Jira, or moves off it, your test history is part of that project.

Independent tools invert the trade. You integrate with the tracker instead of living inside it, which means the integration quality becomes a criterion in its own right (see below), and you own your test data's lifecycle separately from your project management tooling. If you are undecided, the practical tiebreaker is ownership: if the QA team cannot get an admin change made in Jira within a week, do not put your test suite in there.

When you should not buy a test management tool at all

There is a size below which a dedicated tool costs more than it returns, and vendors have no reason to tell you where it is. Three situations where the honest answer is "not yet":

The counter-signal, meaning it probably is time: you are being asked for evidence of what was tested and by whom, more than once a quarter, by someone who will not accept a screenshot. That question is what a test management system answers structurally, and a spreadsheet answers by luck. We covered the crossover in more detail in test management vs spreadsheets.

The exit test: export your data before you sign

This is the criterion the entire SERP mentions in a bullet and nobody tests. Every vendor's page says "easy migration". What matters is the reverse trip, and the evidence that it is lossy comes from the vendors themselves, in their own migration documentation, describing each other.

Four independent vendor sources converge on the same finding: attachments and custom field data are the systematic casualty of test management migration, in every direction.

None of that is a scandal. It is what happens when four products model a test case slightly differently and the interchange format is a flat file. But it tells you what to check, and it tells you that the check has to be empirical, because no vendor page lists its own export limitations. TestRail's export article, for example, documents XML, CSV and Excel output and no limitations at all; the limitation appears only in someone else's import guide.

How to run the exit test in an afternoon

Take a hundred cases from your current tool that are representative rather than convenient: some with screenshots, some with populated custom fields, some with steps that contain tables or code, some linked to requirements and to defects, and a few with meaningful version history. Import that set into each shortlisted trial. Then export it back out of the trial, in every format the tool offers, and compare.

What to look for, in the order that costs the most when it is missing:

  1. Attachments. Are the images in the export at all, or only referenced by a URL that stops resolving when the account closes? A URL reference is not portability.
  2. Custom fields. Do they come out as columns with their values, or only the ones that map onto the destination's built-in schema?
  3. Step structure. Do separated steps with individual expected results survive, or do they collapse into one text blob?
  4. Links. Requirement links, defect links, and the mapping between an automated test and the manual case it covers.
  5. Execution history. Almost never included. Decide now whether you can live with that, because the answer determines whether you migrate or run both systems in parallel through a release.
  6. Version history. Assume it does not travel. If your regulator or your internal audit expects it, that is a hard requirement to put in writing before you sign.

Do the same exercise through the API, not only the UI export, and note the difference. On several tools the API carries data the UI export drops, which changes the migration from an afternoon to a scripting job but makes it possible. Qase's list-cases endpoint, for example, accepts a page size between 1 and 100 with a default of 10, so a 20,000-case export is a paginated job rather than a single call. Plan for that shape of work in advance.

Write the result into the contract discussion. "We can export our data including attachments and custom field values" is a sentence a vendor will either confirm in writing or quietly qualify, and the qualification is the useful part. For the specific case of leaving TestRail we documented what each route loses in exporting test cases from TestRail.

On the way in, the same rigour applies in reverse. A CSV import that requires you to flatten steps and drop images will cost a person a fortnight of cleanup that nobody budgeted. A dedicated import path from your current tool is worth more than a long feature list, which is why QAM Hub ships a TestRail import wizard that connects to the instance and maps suites, sections, cases, custom fields and runs, with resume after interruption. It is honest to say what that does not cover: everything other than TestRail migrates through CSV and the API, the same as elsewhere, and our CSV import and export guide spells out the field mapping.

What a test record actually has to hold

Before comparing editors, agree on what a case must contain in your organisation, because that is what makes two tools genuinely different. If you want a neutral reference rather than a vendor's field list, ISO/IEC/IEEE 29119-3:2021 is the documentation part of the software testing standard series and provides templates and examples for test documentation covering manual and automated, scripted and unscripted testing. It is not a shopping list, and buying a tool because it is "29119 compliant" is meaningless. It is useful as an argument-settler when your team disagrees about whether preconditions belong in the case or the suite.

The fields that most often turn out to be load-bearing:

Tier gating: price the plan you will need in year two

The most predictable budget failure in this category is buying the mid tier because the feature you needed on day one is in it, then discovering that the features you need on day 400 are all one tier up, and the upgrade applies to every seat.

The capabilities most commonly gated to the top tier, with vendor documentation to check rather than sales claims to trust:

Two practical moves. First, list the compliance and administration requirements your security team will impose within eighteen months (SSO is usually the first, audit logs the second) and price the tier that contains them, not the one that contains today's must-haves. Second, ask what happens at renewal if you downgrade: which features degrade, and whether the data created by a top-tier feature remains readable on a lower plan.

QAM Hub's own gating is worth stating plainly for the same reason. Two per-seat plans, Standard and Advanced. Suites, cases, versions and templates, checklists, runs, milestones, requirements traceability, Playwright and Cypress import, dashboards and reports, API tokens and MCP access, personal 2FA and free viewer seats are all Standard. Quality and coverage analytics, release readiness, two-way tracker sync, organization audit logs, Google SSO, organization-wide 2FA enforcement and scheduled email reports are Advanced. If SSO enforcement across the organisation is a security requirement, that is the Advanced plan, and you should budget for it rather than discover it.

Automation results have to land in the same record as manual ones

Half of the value of a test management system in a mixed team is having one answer to "what is the state of this release" instead of two dashboards that disagree. That requires more than an import endpoint.

What to test in a trial, with your own pipeline rather than the vendor's sample data:

We went through the mixed-suite reporting problem in more depth in best test management tools 2026.

Reporting that survives a follow-up question

Every tool in the category produces a pass rate. The difference shows up on the second question, when a director asks which requirements are untested, or whether last week's failures are the same failures as this week's.

Coverage against requirements is the report that justifies the purchase to anyone outside QA, and it only works if requirements exist in the system or arrive from the tracker. Check the direction of that flow during the trial: pulling requirements from Jira, GitHub, GitLab or Linear is a different capability from creating an issue when a test fails, and tools differ on which of the two they do well. Then check whether reports are exportable in a form a non-user can read, whether saved report configurations survive so nobody rebuilds filters weekly, and whether reporting spans projects. Cross-project reporting is frequently a top-tier feature, and it is exactly what a QA manager with six products needs on day one.

The 2026 State of Testing Report from PractiTest, now in its 13th edition, found that 56% of teams are measured on test coverage. If your organisation is one of them, the coverage report is not a nice-to-have and its definition matters: requirement coverage and code coverage are different measurements, and quoting one while meaning the other is the most common reporting error in QA.

How to interrogate the AI claims

Every vendor in this category now ships AI features, and the marketing has converged to the point where the words no longer separate the products. The research does separate the outcomes. Capgemini, Sogeti and OpenText's World Quality Report 2025-26, based on a survey of more than 2,000 senior executives across 22 countries and 10 sectors published in November 2025, found 89% of responding organisations piloting or deploying GenAI-augmented workflows, but only 15% with an enterprise-wide implementation. The average reported productivity gain was 19%, and about a third of respondents saw minimal gains. The barriers respondents named were data privacy risk (67%), integration complexity (64%) and hallucination or reliability concerns (60%). These are executives rather than testers, so read the numbers as budget-holder sentiment, which is what they are.

PractiTest's 2026 report puts AI adoption in testing at 76.8%, with 70% using it for test case creation and 19.9% for risk identification. The gap between those two figures is the useful part: AI is being used where output is cheap to check and avoided where a wrong answer is expensive.

Four questions that separate a working feature from a demo:

Katalon's 2025 State of Software Quality report, which surveyed over 1,500 quality professionals across North America, Europe and Asia-Pacific, found 30% of the teams it classed as advanced were investing in test management platforms. Adoption at that level tends to follow automation maturity rather than lead it, which is an argument for fixing your automation reporting before buying AI features you will not have the data to ground.

The API is the part you need at the worst possible moment

API quality is a boring criterion that becomes the only criterion during a migration, an audit, or the week your reporting requirement changes. Three checks, all of which take under an hour:

Read the rate limits before you read the endpoint list. TestRail publishes 180 requests per minute on Professional and 300 on Enterprise; Qase documents a maximum page size of 100 on its list endpoints. Neither is a problem until you are pushing results from forty parallel CI jobs or pulling 20,000 cases, and then it is a design constraint on your integration.

Check that writes are as complete as reads. Plenty of tools expose everything through the API for reading and only a subset for writing, which quietly makes bulk correction impossible. And check token scoping: whether an API token is user-bound, whether it can be limited to one project, and whether its use appears in an audit log. If AI agents will touch the system at all, that question moves from housekeeping to security. An MCP server is becoming standard here (QAM Hub includes API tokens and MCP access on both plans, and Qase ships MCP on every plan including free), and the governance question it raises is write access, which we looked at separately in what a test management system is and does.

Cost: the model decides more than the sticker price

Three pricing models are in play in this category, and they behave differently as you grow.

Per-seat SaaS with a paid or free viewer tier is the most common. The number that matters is not the seat price but who counts as a seat: if your product owners, support leads and developers need to read results, a tool that charges full price for read access costs several times its list price in a mixed organisation. Ask for the viewer ratio explicitly. Qase sells collaborator seats separately; QAM Hub gives one free viewer seat per paid seat, one to one, which is a ratio rather than the "unlimited viewers" claim you should distrust wherever you see it.

Per-seat with a hard Professional and Enterprise split, as at TestRail, means your cost is determined by which tier holds SSO and audit logging rather than by headcount. TestRail also documents a ten-seat minimum and a twelve-month minimum contract for its on-premise Server edition, which is the kind of term that decides an evaluation for a small team.

Marketplace-tiered licensing bound to the Jira user count, as with Xray and Zephyr, means your test management bill scales with a number that has nothing to do with how many people do testing. In a company with 400 Jira users and 8 testers, that is the whole calculation.

Then add the parts that never appear in a pricing table: migration effort in person-days, the storage tier your artefacts will need, the training time for a tool with a steep editor, and whatever the top tier costs when your security team requires SSO. The published price is usually the smallest of those numbers in year one. QAM Hub's own structure is two per-seat plans in EUR and USD, monthly or annual, with a one-month trial that needs no card; the current figures are on the pricing page, and after the trial nothing is deleted, the workspace is blocked until a plan is paid for.

Running a trial that tests something

A trial spent clicking through the UI tells you the UI is fine. Two weeks structured like this tells you whether the tool works for your team.

Week one: load real data. Import a hundred representative cases, connect one issue tracker, push results from one real automated suite, and invite one person from outside QA to read a report. Every one of those four steps is where evaluations discover the thing the demo hid.

Week two: run a real cycle. Execute one small regression round with two testers working simultaneously, file a defect from a failed test, reopen a completed run and observe what happens to the recorded result, then export everything and diff it against what you imported.

Score against requirements you wrote before you saw any tool, and weight them. A flat checklist where "has custom fields" counts the same as "our data is portable" produces a defensible-looking number and a wrong answer. Involve the people who will use it daily; the most common failure mode in this category is a tool chosen by a manager and rejected by the testers, and its symptom is a suite that stops being updated within two quarters.

The checklist

Grouped by when you use it. Items in each group are ordered by consequence.

Before the shortlist

  1. Do we need a dedicated tool yet, or is the pain upstream of tooling?
  2. Does our test data belong inside Jira or beside it? Who owns Jira admin, and how fast do they move?
  3. What are our data residency and retention obligations, in writing?
  4. What do our security and compliance teams require within eighteen months (SSO, audit logs, MFA enforcement, IP restriction)?
  5. How many people need read access versus write access?

During the trial

  1. Import 100 real cases with attachments, custom fields, structured steps, links and history.
  2. Export them back out, in every available format and through the API, and diff. Record exactly what is lost.
  3. Push results from one real automated suite through the vendor's reporter, and confirm they map to manual cases.
  4. Confirm what artefacts are retained and for how long, and what is never auto-removed.
  5. Create a defect in your tracker from a failed test, and check the link is stored on both the case and the run.
  6. Pull requirements from the tracker and generate a coverage report from them.
  7. Run a two-tester execution round simultaneously, including reopening a completed run.
  8. Give a report to someone outside QA and watch them read it.
  9. Check the API rate limit, the page size, whether writes cover the same objects as reads, and whether tokens can be scoped and audited.
  10. Test the AI features on your own material, and count how many outputs a reviewer accepts unchanged.

Before signing

  1. Which of our requirements are in the tier above the one we are buying? Price that tier.
  2. What is the viewer ratio or collaborator price, as a number?
  3. How is AI billed: included, credit packs with overage, or run caps?
  4. What is the migration effort in person-days, and who is doing it?
  5. What does the vendor commit to in writing about exporting our data, including attachments and custom field values?
  6. What happens at the end of the contract: how long is the data readable, and in what format?
  7. What are the minimum seats and minimum term?

What to prioritize, and what to leave alone

Spend your evaluation time on data portability, tier gating and the automation-to-manual mapping. Those three determine whether the tool is still the right tool in two years, and all three are invisible in a feature comparison. Spend an hour, not a week, on the editor: every serious product in this category writes a decent test case, and the differences are preferences rather than costs.

Do not over-engineer the scoring model. A weighted matrix with 60 criteria produces a total that nobody trusts and that hides the two or three decisions actually being made. Fifteen weighted requirements, agreed before demos start, are enough.

And be honest about sequencing. If your requirements are not written down anywhere, if defects live in chat, or if your automation results are not reliable enough to report on, fix that first. A test management system makes a working process faster and a broken process better documented, and only one of those is worth a subscription.

QAM Hub is built by QA Madness, who published this guide; the competitor details here reflect current public vendor documentation as of September 2026 and are worth re-checking at the source before you decide. If you want the side-by-side view rather than the criteria, we keep it on the comparison pages, and the tool-by-tool write-ups live in TestRail alternatives.

Questions that come up during evaluations

How many tools should we shortlist, and how long should the evaluation take?

Three tools and about four weeks is the shape that works: one week to agree requirements and run demos, two weeks of parallel trials on real data, one week to negotiate and decide. Two tools is too few to calibrate what is normal in the category; five means nobody loads real data into any of them, and the evaluation degrades into a comparison of marketing pages. If a trial period is shorter than two weeks, ask for an extension at the start rather than at the end; vendors grant it routinely and refusing is itself informative.

Who should be in the evaluation team?

At minimum: the person who will administer the tool, two testers who will use it daily, one automation engineer who will wire up the pipeline, and whoever will be asked to read the reports. Bring security in early enough to state the SSO and audit requirements, because that requirement usually changes which tier you are buying and therefore the budget. Keep the group small enough to decide; the failure mode at the other extreme is a committee that scores everything and commits to nothing.

What if the tool we want has no migration path from the tool we have?

Then the decision is whether to migrate at all. Three options, in order of how often they work. Migrate the active subset only: current regression suites and anything touched in the last two quarters, typically a third of the library, and archive the rest as a read-only export you keep. Run both systems for one release, with the old one read-only, which costs two months of double licensing and removes the risk of discovering a gap after the old contract lapses. Or script it against both APIs, which is the right answer above roughly 5,000 cases and needs a developer for a week, not a tester for a month. What rarely works is a manual re-entry project, because it stops being resourced somewhere around case 400.